Sequencing Studies Demonstrate Scope of Genetic Information Accessible in Circulating Tumor DNA | GenomeWeb

Studies published by two independent research teams this past week are extending the scope of sequencing-based analyses applied to cell-free tumor DNA circulating in cancer patients' blood.

Together, the proof-of-principle studies point to the circulating tumor DNA both as a source of information for cataloging the genes and pathways involved in treatment resistance or relapse and as a source of information on metastatic disease in a clinical setting.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.